Is a complete CALC research report available?

No complete published report is available for CalciMedica, Inc. (CALC) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

CalciMedica, Inc. (CALC)

NASDAQ: CALC · USD

$0.84

+0.10 (+13.1%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first CALC analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	13.3M
Net income (ttm)	-19.5M
EPS (ttm)	-$1.27
Shares out	15.8M
Volume	317,959
Beta	1.18
Price target	$10.5	+1150.0%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -19.5M
EPS (ttm): -$1.27
Market cap: 13.3M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All CALC indicators

Market & fundamental data

Available fields

179

Groups with data

Currency

USD

Showing 179 of 179 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001534133
Company name	CalciMedica, Inc.
Country	United States
Country code	US
Cusip	38942Q202
Employees	16
Employees Change	2%
Employees Change Percent	14.29
Enterprise value	$10.3M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US38942Q2021
Last refreshed	2026-07-31
Market cap	$13.3M
Market cap category	Nano-Cap
Price	$0.84
Price currency	USD
Sector	Healthcare
Sector PE	45.56
Sector PE Fwd	24.38
Sic	2834
Symbol	CALC
Website	https://calcimedica.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-166.55%
FCF yield	-180.45%

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-19.5M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Profit Per Employee	$-1.2M
Profitable Quarters	$1
ROA	-81.85
Roa5y	-151.7
ROCE	-674.6
ROE	-399.5
ROIC	-110.8

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-77.8%
Cagr3y	-38.05%
EPS Growth Quarters	1
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$8.6M
Cash	$8.2M
Current Assets	$8.6M
Current Liabilities	$5.3M
Debt	$6.7M
Equity	$-1.1M
Interest Coverage	-17.18
Liabilities	$9.7M
Long Term Assets	$54,000
Long Term Liabilities	$4.4M
Net Cash	$1.5M
Net Cash By Market Cap	$12.48
Net Cash Growth	-90.86%
Tangible Book Value	$-1.1M
Tangible Book Value Per Share	$-0.07
WACC	12.37

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.61
Net Working Capital	$-2.4M
Quick ratio	1.54
Working Capital	$3.2M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-25.12%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-77.78%
200-day SMA	2.04
3Y total return	-76.24%
50-day SMA	0.82
50-day SMA vs 200-day SMA	50under200
All Time High	8.59
All Time High Change	-90.22%
All Time High Date	2023-06-14
All Time Low	0.46
All Time Low Change	82.37%
All Time Low Date	2026-03-02
ATR	0.1
Beta	1.18
Beta1y	0.18
Beta2y	-0.3
Ch YTD	-87.25
High	0.86
High52	7.2
High52 Date	2026-01-02
High52ch	-88.33%
Low	0.74
Low52	0.46
Low52 Date	2026-03-02
Low52ch	82.37%
Ma50ch	2.99%
Premarket Change Percent	0
Premarket Price	$0.74
Price vs 200-day SMA	-58.9%
RSI	53.93
RSI Monthly	42.02
RSI Weekly	41.03
Sharpe ratio	-0.15x
Sortino ratio	-0.15
Total Return	-25.12%
Tr YTD	-87.25
Tr1m	-14.89%
Tr1w	17.34%
Tr3m	50.81%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	3
Analyst Count Top	2
Analyst Price Target Top	$10
Analyst Ratings	Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.27
Operating Income	$-22.2M
Price target	$10.5
Price Target Change	$1,150
Price Target Change Top	$1,090

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	1,544,617%
Float Percent	9.78%
Net Borrowing	-102,000
Shares Insiders	17.82%
Shares Institutions	31.14%
Shares Out	15,798,031
Shares Qo Q	3.08%
Shares Yo Y	25.12%
Short Float	62.2%
Short Ratio	0.29
Short Shares	6.08

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-24.2M
Adjusted OCF	-24,139,000
Average Volume	290,893.55x
Bv Per Share	-0.07
CAPEX	$-19,000
Ch1m	-14.89
Ch1w	17.34
Ch1y	-77.78
Ch3m	50.81
Ch3y	-76.24
Ch6m	-17.65
Change	13.09%
Change From Open	10.54
Close	0.74
Days Gap	2.3
Depreciation Amortization	38,000
Dollar Volume	267,085.6
Earnings Date	2026-08-10
Earnings Time	bmo
EBIT	$-22.2M
EBITDA	$-22.2M
EPS	$-1.27
F Score	1
FCF	$-21.2M
FCF EV Yield	-206.17x
FCF Per Share	$-1.34
Financing CF	4,470,000
Fiscal Year End	December
Founded	2,011
Investing CF	12,294,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-12
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-03
Ma150	1.48
Ma150ch	-43.13%
Ma20	0.81
Ma20ch	4.33%
Net CF	-4,392,000
Next Earnings Date	2026-08-11
Open	0.76
Optionable	Yes
Position In Range	83.39
Post Close	0.84
Postmarket Change Percent	2.98
Postmarket Price	$0.87
Ppne	43,000
Pre Close	0.74
Price Date	2026-07-30
Relative Volume	1.09x
Share Based Comp	2,983,000
Tr6m	-17.65%
Us State	California
Volume	317,959

CalciMedica, Inc. (CALC)

Coverage state: Market snapshot only — no published research

Generate the first CALC analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · CALC

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All CALC indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on CALC

Frequently asked questions